Industry news

What makes a modern-day biotech?

FierceBiotech

If biotechnology is the use of living cells and molecules to make biological products, does this mean all companies producing biological products or solutions are classified as a biotech?

About 0.5 trillion rubles are allocated for procurement of VED drugs in Russia

GMP News

Notwithstanding the market economy, the state must constantly monitor the prices of medicines, because this issue concerns everyone who lives in Russia. This statement was made by Prime Minister Dmitry Medvedev in his interview with Russian TV channels.

Russian government will support drug compounding

GMP News

Russian government will give its backing to a drug compounding. Senators and experts discussed this matter in the press centre of “Parliamentary Gazette” – the official gazette established by Russia’s Federation Council.

WHO published its study report on falsified medical products

GMP News

An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from World Health Organization (WHO).

Ferring and Ache Laboratorios Farmaceuticos open a joint nanotechnology centre

GMP News

Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos, a Brasilian pharmaceutical company, announced the inauguration of their joint nanotechnology centre in São Paulo, Brazil. Focused exclusively on nanotechnology research and development, the centre forms the first phase in a long term collaboration to optimise patient care through enhanced drug delivery systems and product solutions.

Russian market of non-opioid analgesics and antipyretics reaches 22.3 billion rubles

GMP News

Since 2015, the sales of non-opioid analgesics and antipyretics have fallen significantly in physical terms, but are still growing, if calculated based on prices of final consumption, according to retail audit data released by IQVIA.

Draft law on accelerated registration of foreign medicines approved in Russia

GMP News

At a meeting held on November 23, 2017, the Government of the Russian Federation approved the draft federal law “On Amendments to the Federal Law on the Circulation of Medicines” and decided to submit it to the State Duma in accordance with the established procedure.

How much is an FDA shortcut worth to drug developers hustling to an OK? Holding steady at $125M, cash

John Carroll / Endpoints News

Authorities decide to simplify the entry of foreign drugs to the Russian market

GMP News

According to the Russian Ministry of Industry and Trade, this institution has prepared the draft law “On Amendments to the Federal Law On Circulation of Medicines”, intending to reduce time required for foreign medicines to enter the Russian market.

EMA published a set of GMP guidelines for advanced therapies

GMP News

The European Commission has published a set of guidelines on good manufacturing practice (GMP) specific to advanced therapy medicinal products (ATMPs). ATMPs are medicines for human use that are based on genes or cells. These therapies offer ground-breaking new opportunities for the treatment of diseases and injuries. They are particularly important for severe, untreatable or chronic diseases for which conventional approaches have proven to be inadequate.